MARKET

ANGO

ANGO

AngioDynamics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.09
-0.04
-0.44%
Opening 10:47 08/12 EDT
OPEN
9.24
PREV CLOSE
9.13
HIGH
9.27
LOW
9.03
VOLUME
41.99K
TURNOVER
--
52 WEEK HIGH
19.80
52 WEEK LOW
7.48
MARKET CAP
342.65M
P/E (TTM)
-2.0871
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ANGO stock price target is 14.00 with a high estimate of 14.00 and a low estimate of 14.00.

EPS

ANGO News

More
New Strong Sell Stocks for August 5th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Zacks · 08/05 12:32
Edited Transcript of ANGO.OQ earnings conference call or presentation 16-Jul-20 12:00pm GMT
Q4 2020 AngioDynamics Inc Earnings Call
Thomson Reuters StreetEvents · 08/04 12:09
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will participate i
Business Wire · 08/03 20:01
New Strong Sell Stocks for August 3rd
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Zacks · 08/03 13:32
Acutus Medical Files For IPO For Commercialization Push
Seeking Alpha - Article · 07/23 18:47
AngioDyanamics (ANGO) Reports Q4 Loss, Revenues Lag Estimates
AngioDyanamics (ANGO) witnessed revenue decline across all business segments in Q4.
Zacks · 07/17 12:14
64 Biggest Movers From Yesterday
Gainers InnerWorkings, Inc. (NASDAQ: INWK) shares jumped 115.9% to close at $2.85 on Thursday after HH Global announced plans to acquire the company for $3 per share.
Benzinga · 07/17 09:08
AngioDynamics Inc (ANGO) Q4 2020 Earnings Call Transcript
The news release detailing the fourth quarter and fiscal year 2020 results crossed the wire earlier this morning and is available on the Company's website. This conference call is also being broadcast live over the Internet at the Investors section of the Com
Motley Fool · 07/16 18:30

Industry

Medical Equipment, Supplies & Distribution
+1.45%
Healthcare Equipment & Supplies
+1.52%

Hot Stocks

Symbol
Price
%Change

About ANGO

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.
More

Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.